Arrib, Wilbert .

HRN: 26-33-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/04/2024
12/11/2024
IV
600MG
Q8
SEPSIS SEC TO DM FOOT
Waiting Final Action 
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/05/2024
12/11/2024
IV
2.25g
Q6
SEPSIS SEC TO DM FOOT
Waiting Final Action 
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2024
12/05/2024
IV
4.5g
LOADING DOSE ONCE
SEPSIS SEC TO DM FOOT
Waiting Final Action 
12/31/2024
CEFTAZIDIME 1GM (VIAL)
12/31/2024
12/31/2024
IV
2g
Loading Dose
DM Foot Infected
Waiting Final Action 
12/31/2024
CEFTAZIDIME 1GM (VIAL)
01/01/2025
01/07/2025
IV
1g
Q12
Dm Foot Infected
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: